Calyxo develops the CVAC Aspiration system designed to use irrigation and aspiration to remove kidney stones with the goal of a surgically stone-free outcome.

According to a news release, Questa Capital and CRG led the Series C funding round completed today.

Calyxo was founded in February 2016 to address the profound need for improved kidney stone treatment. Kidney stone disease is a common problem that is painful and consumes vast amounts of healthcare resources each year. Calyxo is focused on delivering innovative solutions to better meet the needs of kidney stone patients and transform the care of this condition.